Viewing Study NCT01284166


Ignite Creation Date: 2025-12-24 @ 4:27 PM
Ignite Modification Date: 2025-12-29 @ 8:25 AM
Study NCT ID: NCT01284166
Status: WITHDRAWN
Last Update Posted: 2013-07-18
First Post: 2011-01-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of Triple Combination Therapy With Dorzolamide Hydrochloride / Brimonidine Tartrate / Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension
Sponsor: Allergan
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module